Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.

作者: Dajun D. Sun , Ping I. Lee

DOI: 10.1016/J.JCONREL.2015.06.004

关键词:

摘要: The objective of the current study is to mechanistically differentiate dissolution and supersaturation behaviors amorphous drugs from solid dispersions (ASDs) based on medium-soluble versus medium-insoluble carriers under nonsink conditions through a direct head-to-head comparison. ASDs indomethacin (IND) were prepared in several polymers which exhibit different solubility acidic (pH 1.2) basic 7.4) media. selected range water-soluble (e.g., PVP Soluplus) water-insoluble ethylcellulose Eudragit RL PO) those only soluble an or medium E100, L100, HPMCAS). At 20 wt.% drug loading, DSC powder XRD analysis confirmed that majority incorporated IND was present state. Our results confirm whether carrier matrix determines release mechanism ASD systems has impact rate generation, thus turn affecting evolution systems. For example, conditions, governed by dissolution-controlled leading initial surge followed sharp decline concentration due rapid nucleation crystallization. In contrast, more gradual as regulated diffusion-controlled built up gradually sustained over extended period time without any apparent decline. Since tested can be switched insoluble simply changing pH medium, obtained here provide unequivocal evidence proposed transition kinetic profiles same system induced changes pH.

参考文章(25)
Lynne S. Taylor, George Zografi, Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharmaceutical Research. ,vol. 14, pp. 1691- 1698 ,(1997) , 10.1023/A:1012167410376
Tadahito Takahashi, Michihiro Yamaguchi, Host-guest interactions between swelling clay minerals and poorly water-soluble drugs Journal of Colloid and Interface Science. ,vol. 146, pp. 556- 564 ,(1991) , 10.1016/0021-9797(91)90219-X
Dajun D. Sun, Ping I. Lee, Evolution of Supersaturation of Amorphous Pharmaceuticals: The Effect of Rate of Supersaturation Generation Molecular Pharmaceutics. ,vol. 10, pp. 4330- 4346 ,(2013) , 10.1021/MP400439Q
David E. Alonzo, Yi Gao, Deliang Zhou, Huaping Mo, Geoff G.Z. Zhang, Lynne S. Taylor, Dissolution and Precipitation Behavior of Amorphous Solid Dispersions Journal of Pharmaceutical Sciences. ,vol. 100, pp. 3316- 3331 ,(2011) , 10.1002/JPS.22579
Petra A. Priemel, Riikka Laitinen, Holger Grohganz, Thomas Rades, Clare J. Strachan, In situ amorphisation of indomethacin with Eudragit® E during dissolution. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 85, pp. 1259- 1265 ,(2013) , 10.1016/J.EJPB.2013.09.010
Patrick Augustijns, Marcus E. Brewster, Supersaturating Drug Delivery Systems: Fast is Not Necessarily Good Enough Journal of Pharmaceutical Sciences. ,vol. 101, pp. 7- 9 ,(2012) , 10.1002/JPS.22750
Karel Six, Tinne Daems, Jan de Hoon, Anne Van Hecken, Marleen Depre, Marie-Paule Bouche, Paul Prinsen, Geert Verreck, Jef Peeters, Marcus E. Brewster, Guy Van den Mooter, Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion European Journal of Pharmaceutical Sciences. ,vol. 24, pp. 179- 186 ,(2005) , 10.1016/J.EJPS.2004.10.005
Michiel Van Speybroeck, Randy Mellaerts, Raf Mols, Thao Do Thi, Johan Adriaan Martens, Jan Van Humbeeck, Pieter Annaert, Guy Van den Mooter, Patrick Augustijns, Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica. European Journal of Pharmaceutical Sciences. ,vol. 41, pp. 623- 630 ,(2010) , 10.1016/J.EJPS.2010.09.002
Jan Bevernage, Joachim Brouwers, Marcus E. Brewster, Patrick Augustijns, Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. International Journal of Pharmaceutics. ,vol. 453, pp. 25- 35 ,(2013) , 10.1016/J.IJPHARM.2012.11.026
Payam Zahedi, Ping I. Lee, Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 65, pp. 320- 328 ,(2007) , 10.1016/J.EJPB.2006.10.025